Iris Kersten

472 total citations
22 papers, 265 citations indexed

About

Iris Kersten is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Iris Kersten has authored 22 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 14 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Iris Kersten's work include Intracerebral and Subarachnoid Hemorrhage Research (15 papers), Alzheimer's disease research and treatments (14 papers) and Cerebrovascular and genetic disorders (6 papers). Iris Kersten is often cited by papers focused on Intracerebral and Subarachnoid Hemorrhage Research (15 papers), Alzheimer's disease research and treatments (14 papers) and Cerebrovascular and genetic disorders (6 papers). Iris Kersten collaborates with scholars based in Netherlands, United States and Germany. Iris Kersten's co-authors include Renée de Mutsert, Egbert R. Boevé, Mark F. Wildhagen, Fritz H. Schröder, Monique J. Roobol, Ardy van Helvoort, H. Bea Kuiperij, Marcel M. Verbeek, J. R. Bierich and Floris H.B.M. Schreuder and has published in prestigious journals such as Stroke, Annals of Neurology and Journal of Neurochemistry.

In The Last Decade

Iris Kersten

20 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Kersten Netherlands 9 78 62 57 45 36 22 265
Huiyan Yu China 11 106 1.4× 44 0.7× 141 2.5× 16 0.4× 34 0.9× 25 338
S. Salvati Italy 12 62 0.8× 27 0.4× 102 1.8× 76 1.7× 18 0.5× 32 357
Li‐Wen Chu Taiwan 9 150 1.9× 30 0.5× 159 2.8× 17 0.4× 17 0.5× 18 391
S. Younes Tunisia 8 54 0.7× 234 3.8× 116 2.0× 34 0.8× 38 1.1× 46 458
Jeppe Haslund-Vinding Denmark 7 48 0.6× 56 0.9× 82 1.4× 24 0.5× 18 0.5× 13 304
Marco Oliveti Italy 7 41 0.5× 18 0.3× 111 1.9× 15 0.3× 37 1.0× 8 291
Jan Schepel New Zealand 4 153 2.0× 41 0.7× 83 1.5× 11 0.2× 53 1.5× 6 307
Katherine Powers United States 6 38 0.5× 42 0.7× 72 1.3× 7 0.2× 59 1.6× 11 332
Tolga Berkman United States 6 113 1.4× 13 0.2× 120 2.1× 14 0.3× 10 0.3× 8 295

Countries citing papers authored by Iris Kersten

Since Specialization
Citations

This map shows the geographic impact of Iris Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kersten more than expected).

Fields of papers citing papers by Iris Kersten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kersten. The network helps show where Iris Kersten may publish in the future.

Co-authorship network of co-authors of Iris Kersten

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Kersten. A scholar is included among the top collaborators of Iris Kersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Kersten. Iris Kersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pereira, Mariana, Frederik D. Weber, David A. Neville, et al.. (2024). Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta. Annals of Neurology. 96(1). 46–60. 10 indexed citations
2.
Berg, E. van den, Iris Kersten, Gunnar Brinkmalm, et al.. (2024). Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy. Journal of Neurochemistry. 168(7). 1254–1264. 3 indexed citations
3.
Kort, Anna M. de, Iris Kersten, Hans J. C. T. Wessels, et al.. (2024). Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients. Acta Neuropathologica Communications. 12(1). 6–6. 7 indexed citations
4.
Jäkel, Lieke, Anna M. de Kort, Iris Kersten, et al.. (2024). Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy. Acta Neuropathologica Communications. 12(1). 103–103. 3 indexed citations
5.
Kuiperij, H. Bea, Anna M. de Kort, Iris Kersten, et al.. (2024). Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 16(1). 108–108.
6.
Berg, E. van den, Johanna Nilsson, Iris Kersten, et al.. (2023). Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease. Journal of Alzheimer s Disease. 92(2). 467–475. 4 indexed citations
7.
Kort, Anna M. de, Lieke Jäkel, Iris Kersten, et al.. (2023). Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 15(1). 26–26. 6 indexed citations
8.
Kort, Anna M. de, H. Bea Kuiperij, Lieke Jäkel, et al.. (2023). Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 15(1). 102–102. 8 indexed citations
9.
Zhu, Xiaoyue, Anna M. de Kort, Tainá M. Marques, et al.. (2022). Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. 48(5). e12804–e12804. 2 indexed citations
10.
Kort, Anna M. de, H. Bea Kuiperij, Daniel Alcolea, et al.. (2021). Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 13(1). 160–160. 6 indexed citations
11.
Marques, Tainá M., Anouke van Rumund, Iris Kersten, et al.. (2021). Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. npj Parkinson s Disease. 7(1). 107–107. 17 indexed citations
12.
Zhu, Xiaoyue, Anna M. de Kort, Tainá M. Marques, et al.. (2021). Urokinase plasminogen activator (uPA) as a novel biomarker for cerebral amyloid angiopathy. Alzheimer s & Dementia. 17(S4). 1 indexed citations
13.
Verbeek, Marcel M., Anna M. de Kort, Marieke J.H. Wermer, et al.. (2021). Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls. Alzheimer s & Dementia. 17(S4). 1 indexed citations
14.
Kuiperij, H. Bea, Anna M. de Kort, Iris Kersten, et al.. (2020). Platelet‐derived growth factor receptor‐beta as a potential CSF biomarker for Alzheimer’s disease. Alzheimer s & Dementia. 16(S5). 1 indexed citations
15.
Leijsen, Esther M.C. van, H. Bea Kuiperij, Iris Kersten, et al.. (2018). Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease. Stroke. 49(4). 884–890. 30 indexed citations
16.
Mančíková, Veronika, Lucía Inglada‐Pérez, María Currás-Freixes, et al.. (2014). VEGF, VEGFR3, and PDGFRB Protein Expression Is Influenced by RAS Mutations in Medullary Thyroid Carcinoma. Thyroid. 24(8). 1251–1255. 15 indexed citations
17.
Schröder, Fritz H., Monique J. Roobol, Egbert R. Boevé, et al.. (2005). Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement. European Urology. 48(6). 922–931. 95 indexed citations
18.
Bierich, J. R., et al.. (1959). PLASMACORTICOSTEROIDS AND THEIR RESPONSIVENESS TO CORTICOTROPHIN AFTER LONGTERM THERAPY WITH CORTICOSTEROIDS AND CORTICOTROPHIN. European Journal of Endocrinology. XXXI(I). 40–48. 24 indexed citations
19.
Bierich, J. R. & Iris Kersten. (1959). Untersuchungen zur Pr�fung der Nebennierenrindenfunktion mit Depot-ACTH. Journal of Molecular Medicine. 37(17). 914–917. 1 indexed citations
20.
Kersten, Iris, et al.. (1957). Zur Hydrolyse und Extraktion der Harnoestrogene. Archives of Gynecology and Obstetrics. 188(3). 279–298. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiyan Yu Breakdown of academic impact, for papers by S. Salvati Breakdown of academic impact, for papers by Li‐Wen Chu Breakdown of academic impact, for papers by S. Younes Breakdown of academic impact, for papers by Jeppe Haslund-Vinding Breakdown of academic impact, for papers by Marco Oliveti Breakdown of academic impact, for papers by Jan Schepel Breakdown of academic impact, for papers by Katherine Powers Breakdown of academic impact, for papers by Tolga Berkman
Rankless by CCL
2026